Atlas Trials

Cellbion Co., Ltd.

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Cellbion Co., Ltd.

RecordFirmDate
Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer (NCT07244393)Cellbion Co., Ltd.2025-12-01
A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapy (NCT05547061)Cellbion Co., Ltd.2021-04-12

Track Cellbion Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.